Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tacrolimus for Oral Ulcers in Behcet's Disease
NCT05032248Completed
- Sponsor
- Assiut University
- Start
- Apr 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Tacrolimus Ointment 0.1% Iwaki in Behcet's disease (BD) (2 arms), sponsored by Assiut University. Primary endpoint: Ulcer Severity Score at 3 months. Started Apr 2019; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT05032248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05032248.